Sector: MedicalLIGHTEN UP ENTP INTL (OTCBB: BNVI)
Headlines
- Bionovo Announces Third Quarter 2009 Highlights and Financial Results
Nov 05, 2009 04:02 PM | BNVI
- Steven R. Goldstein, M.D., Joins Bionovo's Menerba Medical Advisory Board
Nov 05, 2009 08:03 AM | BNVI
- Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
Oct 29, 2009 08:02 AM | BNVI
- Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
Oct 20, 2009 08:01 AM | BNVI
- Bionovo Adds Dr. Debu Tripathy to Their Medical Advisory Board
Oct 14, 2009 06:00 AM | BNVI
- Bionovo Announces Pricing of Securities Offering
Oct 02, 2009 09:24 AM | BNVI
- Bionovo Announces Publication Describing the Selective Anti-tumor Activity of its Drug Candidate BN108
Oct 01, 2009 11:17 AM | BNVI
- Bionovo to Present at the Maxim Group Growth Conference
Sep 25, 2009 08:01 AM | BNVI
- Bionovo to Present on Novel Female-Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society
Sep 24, 2009 12:08 PM | BNVI
- Bionovo Notified by NASDAQ of Minimum Bid Price Deficiency
Sep 21, 2009 04:05 PM | BNVI
- Bionovo Announces Second Quarter 2009 Highlights and Financial Results
Aug 10, 2009 03:56 PM | BNVI
- Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer
Aug 04, 2009 07:31 AM | BNVI
- Bionovo, Inc. to Announce Second Quarter Fiscal Year 2009 Financial Results on Monday, August 10, 2009
Aug 03, 2009 04:15 PM | BNVI
- Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference
Jul 29, 2009 09:03 AM | BNVI
- Bionovo's Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity
Jul 17, 2009 08:01 AM | BNVI
- Bionovo Announces Arbitration Decision in Lawsuit Filed by Former Officer - All Claims Denied
Jun 11, 2009 04:30 PM | BNVI
- Bionovo Appoints Dr. Klaus Kohl as Chief Technical Officer
Jun 02, 2009 08:03 AM | BNVI
- Bionovo Announces First Quarter 2009 Highlights and Financial Results
May 07, 2009 04:06 PM | BNVI
- Bionovo, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Thursday, May 7, 2009
Apr 30, 2009 09:01 AM | BNVI
- Bionovo Announces Publication of Data on Active Compound and Mechanism of Action for Its Preclinical Cancer Treatment, BN108
Apr 20, 2009 09:04 AM | BNVI
- Form 4 BIONOVO INC For: Jul 09 Filed by: TAGLIAFERRI MARY (10K)
Jul 14, 2009 02:48 PM
- Form 4 BIONOVO INC For: Jul 09 Filed by: COHEN ISAAC (10K)
Jul 14, 2009 02:46 PM
- Form 4 COHEN ISAAC For: Mar 23 (10K)
Jun 16, 2009 08:03 PM
- Form 4/A TAGLIAFERRI MARY For: Mar 23 (10K)
Jun 16, 2009 08:02 PM
- Form 4 TAGLIAFERRI MARY For: Jun 02 (10K)
Jun 03, 2009 06:26 PM
- Form 4 BIONOVO INC For: Nov 28 Filed by: DRAPEAU LOUIS (10K)
Dec 02, 2008 08:48 PM
- Form 4/A VANDERHOOF MICHAEL D For: Jun 17 (10K)
Jun 30, 2008 07:56 PM
- Form 4/A BAXTER JOHN D For: Jun 17 (10K)
Jun 30, 2008 07:55 PM
- Form 4 BIONOVO INC For: Jun 17 Filed by: BAXTER JOHN D (10K)
Jun 19, 2008 05:28 PM
- Form 4 BIONOVO INC For: Jun 17 Filed by: NAVEH DAVID (10K)
Jun 19, 2008 05:26 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
BNVI
|
Compare to S&P
|
| YTD |
100.00 %
|
65.52 %
|
| 4 Weeks |
-7.54 %
|
-8.54 %
|
| 12 Weeks |
-42.87 %
|
-46.13 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 0.00 %
|
|
EPS Growth in Last Year: 28.57 %
|
|
Sales Growth in Last Quarter: 2,114.29 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
